After going ‘crazy’ over the science, Merck signs up a new partner in the hunt for an HIV cure

Less than a year after inking a $100 million licensing deal with German giant Bayer, Dewpoint Therapeutics has scored another big-time contract, this time with Merck. And this collaboration came together in a particularly unusual fashion.